The MFICM governance structure comprises leading scientists, academics and clinicians both from the CRUK Cambridge Centre and The Mark Foundation for Cancer Research.
Co-Leader ICM, Academic Honorary Consultant in Medical Oncology (Breast); Reader in Department of Oncology, Dep of Oncology
Co-Leader ICM, Senior Group Leader, CRUK Cambridge Institute; Academic Honorary Consultant in Medical Oncology (Ovarian)
Co-Leader ICM, Professor of Surgical Oncology, Dept of Surgery, CI WIRE trial (Renal Cancer)
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.